List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #55,011 to #55,060.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. U.S. Department of Health and Human Services → United States Department of Health and Human Services
  2. U.S. Food and Drug Administration → Food and Drug Administration
  3. U.S. National Institutes of Health → National Institutes of Health
  4. U.S. National Library of Medicine → United States National Library of Medicine
  5. U.S. Public Health Service → United states public health service
  6. U.S. customary unit → United States customary units
  7. U.S. drug regulation → Regulation of therapeutic goods#United States
  8. U. urealyticum → Ureaplasma urealyticum
  9. U. urealyticum biovar 1 → Ureaplasma urealyticum
  10. U. urealyticum biovar 2 → Ureaplasma urealyticum
  11. U.parvum → Ureaplasma urealyticum
  12. U.urealyticum → Ureaplasma urealyticum
  13. U.urealyticum biovar 1 → Ureaplasma urealyticum
  14. U4EA → 4-Methyl-aminorex
  15. UA → Unstable angina / non ST elevation myocardial infarction
  16. UA/NSTEMI ACC/AHA guidelines for immediate management → Unstable angina / non ST elevation myocardial infarction ACC/AHA guidelines for immediate management
  17. UA/NSTEMI inhibitors of RAS → Unstable angina / non ST elevation myocardial infarction inhibitors of RAS
  18. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines Nonsteroidal Anti-Inflammatory Drugs → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines nonsteroidal anti-inflammatory drugs
  19. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid
  20. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines depression → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines depression
  21. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for CCB → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for calcium channel blockers
  22. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for Physical Activity → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for physical activity
  23. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy
  24. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for beta blockers → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for beta blockers
  25. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control
  26. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus
  27. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for inhibitors of the RAS → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for inhibitors of the RAS
  28. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management
  29. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for nitroglycerin → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for nitroglycerin
  30. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation
  31. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy
  32. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management
  33. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy
  34. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines influenza vaccination → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines influenza vaccination
  35. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines patient education → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines patient education
  36. UAD Caine → Lidocaine
  37. UAP → Unstable angina / non ST elevation myocardial infarction
  38. UA / NSTEMI prehospital care → Unstable angina / non ST elevation myocardial infarction prehospital care after onset
  39. UA / NSTEMI prehospital care after onset → Unstable angina / non ST elevation myocardial infarction prehospital care after onset
  40. UA / NSTEMI prehospital care before onset → Unstable angina / non ST elevation myocardial infarction prehospital care before onset
  41. UBC → Unicameral bone cyst
  42. UBC (gene) → Ubiquitin C
  43. UC → Ulcerative colitis
  44. UCC → Transitional cell carcinoma
  45. UCP1 → Thermogenin
  46. UCSF-SCOR → UCSF-SCOR trial
  47. UDP-N-acetylmuramoylalanine-D-glutamate ligase → UDP-N-acetylmuramoyl-L-alanine-D-glutamate ligase
  48. UDP-N-acetylmuramoylalanyl-tripeptide-D-alanyl-D-alanine ligase → UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase
  49. UDP-galactose → Uridine diphosphate galactose
  50. UDP-galactose-4-epimerase deficiency → Galactose epimerase deficiency

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"